These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3756464)

  • 21. Control of oro-facio-lingual movements by the substantia nigra pars reticulata: high-frequency electrical microstimulation and GABA microinjection findings in rats.
    Inchul P; Amano N; Satoda T; Murata T; Kawagishi S; Yoshino K; Tanaka K
    Neuroscience; 2005; 134(2):677-89. PubMed ID: 15987665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.
    Reid M; Herrera-Marschitz M; Hökfelt T; Terenius L; Ungerstedt U
    Eur J Pharmacol; 1988 Mar; 147(3):411-20. PubMed ID: 2454197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ethanol on gamma-vinyl GABA-induced GABA accumulation in the substantia nigra and on synaptosomal GABA content in six rat brain regions.
    Frye GD; Fincher AS
    Brain Res; 1988 May; 449(1-2):71-9. PubMed ID: 3395859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early increase in dopamine release in the ipsilateral striatum after unilateral intranigral administration of lactacystin produces spontaneous contralateral rotations in rats.
    Konieczny J; Lenda T; Czarnecka A
    Neuroscience; 2016 Jun; 324():92-106. PubMed ID: 26964686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct roles for nigral GABA and glutamate receptors in the regulation of dendritic dopamine release under normal conditions and in response to systemic haloperidol.
    Cobb WS; Abercrombie ED
    J Neurosci; 2002 Feb; 22(4):1407-13. PubMed ID: 11850467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of electrical and chemical stimulation of the subthalamic nucleus on the release of striatal dopamine.
    Pazo JH; Höcht C; Barceló AC; Fillipini B; Lomastro MJ
    Synapse; 2010 Dec; 64(12):905-15. PubMed ID: 20939061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine D2, receptor-mediated modulation of the GABAergic inhibition of substantia nigra pars reticulata neurons.
    Martin LP; Waszczak BL
    Brain Res; 1996 Aug; 729(2):156-69. PubMed ID: 8876984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic haloperidol administration enhances the gamma-aminobutyric acid level in the rat striatum without altering the glutamate level.
    Kornhuber J; Kim JS; Kornhuber ME; Kornhuber HH
    Eur Neurol; 1984; 23(4):269-73. PubMed ID: 6541578
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of effects of apomorphine, haloperidol and clozapine on the synthesis and utilization of brain GABA.
    Lindgren S
    J Neural Transm; 1987; 69(1-2):47-57. PubMed ID: 3585320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eye movements induced by microinjection of GABA agonist in the rat substantia nigra pars reticulata.
    Sakamoto M; Hikosaka O
    Neurosci Res; 1989 Feb; 6(3):216-33. PubMed ID: 2710424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposing effects of striatonigral feedback pathways on midbrain dopamine cell activity.
    Grace AA; Bunney BS
    Brain Res; 1985 May; 333(2):271-84. PubMed ID: 2986775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of substantia nigra pars reticulata neurons in the expression of neuroleptic-induced catalepsy.
    Morelli M; Porceddu ML; Imperato A; Di Chiara G
    Brain Res; 1981 Aug; 217(2):375-9. PubMed ID: 6972799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of increasing doses of intracaudate haloperidol upon motor expressions that require an intact substantia nigra pars reticulata and/or superior colliculus in cats.
    Gelissen M; Cools A
    Behav Brain Res; 1988 Mar; 27(3):205-14. PubMed ID: 3358859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haloperidol treatment after high-dose methamphetamine administration is excitotoxic to GABA cells in the substantia nigra pars reticulata.
    Hatzipetros T; Raudensky JG; Soghomonian JJ; Yamamoto BK
    J Neurosci; 2007 May; 27(22):5895-902. PubMed ID: 17537960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between dopamine D1 receptors and gamma-aminobutyric acid mechanisms in substantia nigra pars reticulata of the rat: neurochemical and behavioral studies.
    Trevitt T; Carlson B; Correa M; Keene A; Morales M; Salamone JD
    Psychopharmacology (Berl); 2002 Jan; 159(3):229-37. PubMed ID: 11862355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine modulation of the effects of gamma-aminobutyric acid on substantia nigra pars reticulata neurons.
    Waszcak BL; Walters JR
    Science; 1983 Apr; 220(4593):218-21. PubMed ID: 6828891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of dopamine agonists on gamma-aminobutyric acid (GABA) turnover in the superior colliculus: evidence that nigrotectal GABA projections are under the influence of dopaminergic transmission.
    Melis MR; Gale K
    J Pharmacol Exp Ther; 1983 Aug; 226(2):425-31. PubMed ID: 6875856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin release.
    Broderick PA; Piercey MF
    J Neural Transm (Vienna); 1998; 105(6-7):749-67. PubMed ID: 9826116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GABAergic modulation in the substantia nigra of the striatal dopamine release and of the locomotor activity in rats exposed to helium pressure.
    Balon N; Kriem B; Weiss M; Rostain JC
    Brain Res; 2002 Sep; 948(1-2):82-92. PubMed ID: 12383958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.